Ibtihal Abdallah

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Venous Thromboembolism

Diffusion Weighted Imaging

Top Venues

Clinical and translational science

European journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Majdoleen Al Alawneh, Ahmed Awaisu, Ibtihal Abdallah, Hazem F Elewa, Mohammed Ibn-Mas'ud Danjuma, Kamal M Matar, Akram M ElKashlan, Yasser Elshayep, Fathy Ibrahim, Ousama Rachid
Pharmacokinetics of single-dose rivaroxaban under fed state in obese vs. non-obese subjects: An open-label controlled clinical trial (RIVOBESE-PK). Clinical and translational science 17 (6) (2024)
Majdoleen Al Alawneh, Ahmed Awaisu, Ibtihal Abdallah, Hazem F Elewa, Mohammed Ibn-Mas'ud Danjuma, Kamal M Matar, Akram M ElKashlan, Yasser Elshayep, Fathy Ibrahim, Ousama Rachid
Pharmacokinetics of single-dose rivaroxaban under fed state in obese vs. non-obese subjects: An open-label controlled clinical trial (RIVOBESE-PK). Clinical and translational science 17 (6) (2024)
Majdoleen Al Alawneh, Ahmed Awaisu, Ibtihal Abdallah, Hazem F Elewa, Mohammed Ibn-Mas'ud Danjuma, Kamal M Matar, Akram M ElKashlan, Yasser Elshayep, Fathy Ibrahim, Ousama Rachid
Pharmacokinetics of single-dose rivaroxaban under fed state in obese vs. non-obese subjects: An open-label controlled clinical trial (RIVOBESE-PK). Clinical and translational science 17 (6) (2024)
Majdoleen Al Alawneh, Ousama Rachid, Ibtihal Abdallah, Ahmad Mahfouz, Hazem F Elewa, Mohammed Ibn-Mas'ud Danjuma, Asmaa Ezzeldin Mohamed, Ahmed Awaisu
Trends in prescribing and outcomes in obese versus non-obese patients receiving rivaroxaban therapy: an observational study using real-world data. European journal of clinical pharmacology (2023)